-
1
-
-
0031848146
-
Familial gastrointestinal stromal tumors with germline mutation of the Kit gene
-
Nishida T., Hirota S., Taniguchi M., Nishikaux K., Ohashi A., Takabayashi A., et al. Familial gastrointestinal stromal tumors with germline mutation of the Kit gene. Nat. Genet. 19 (1998) 323-324
-
(1998)
Nat. Genet.
, vol.19
, pp. 323-324
-
-
Nishida, T.1
Hirota, S.2
Taniguchi, M.3
Nishikaux, K.4
Ohashi, A.5
Takabayashi, A.6
-
2
-
-
0031791026
-
A novel gain-of-function mutation of c-Kit gene in gastrointestinal stromal tumors
-
Nakahara M., Isozaki K., Hirota S., Miyagawa J., Hase-Sawada N., Taniguchi M., et al. A novel gain-of-function mutation of c-Kit gene in gastrointestinal stromal tumors. Gastroenterology 115 (1998) 1090-1095
-
(1998)
Gastroenterology
, vol.115
, pp. 1090-1095
-
-
Nakahara, M.1
Isozaki, K.2
Hirota, S.3
Miyagawa, J.4
Hase-Sawada, N.5
Taniguchi, M.6
-
3
-
-
0031857113
-
CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34
-
Sarlomo-Rikala M., Kovatich A., Barusevicius A., and Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod. Pathol. 11 (1998) 728-734
-
(1998)
Mod. Pathol.
, vol.11
, pp. 728-734
-
-
Sarlomo-Rikala, M.1
Kovatich, A.2
Barusevicius, A.3
Miettinen, M.4
-
4
-
-
0032862462
-
Gastrointestinal Stromal Tumors/Smooth muscle Tumors (GISTs) Primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases
-
Miettinen M., Monihan J.M., Sariomo R.M., Kovavitch A.J., Carr N.J., Emory T.S., et al. Gastrointestinal Stromal Tumors/Smooth muscle Tumors (GISTs) Primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am. J. Surg. Pathol. 23 (1999) 1109-1118
-
(1999)
Am. J. Surg. Pathol.
, vol.23
, pp. 1109-1118
-
-
Miettinen, M.1
Monihan, J.M.2
Sariomo, R.M.3
Kovavitch, A.J.4
Carr, N.J.5
Emory, T.S.6
-
5
-
-
0034109008
-
Extragastrointestinal (Soft Tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome
-
Reith J.D., Goldblum J.R., Lyles R.H., and Weiss S.W. Extragastrointestinal (Soft Tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod. Pathol. 13 (2000) 577-585
-
(2000)
Mod. Pathol.
, vol.13
, pp. 577-585
-
-
Reith, J.D.1
Goldblum, J.R.2
Lyles, R.H.3
Weiss, S.W.4
-
6
-
-
12144288616
-
c-Kit and PDGFRA mutations in extragastrointestinal stromal tumor
-
Yamamoto H., Oda Y., Kawaguchi K.I., Nakamura N., Takahira T., Tamiya S., et al. c-Kit and PDGFRA mutations in extragastrointestinal stromal tumor. Am. J. Surg. Pathol. 28 (2004) 479-488
-
(2004)
Am. J. Surg. Pathol.
, vol.28
, pp. 479-488
-
-
Yamamoto, H.1
Oda, Y.2
Kawaguchi, K.I.3
Nakamura, N.4
Takahira, T.5
Tamiya, S.6
-
7
-
-
30344450853
-
Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-20
-
Miettinen M., Sarlomo-Rikala M., and Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-20. Ann. Chir. Gynecol. 87 (1998) 278-281
-
(1998)
Ann. Chir. Gynecol.
, vol.87
, pp. 278-281
-
-
Miettinen, M.1
Sarlomo-Rikala, M.2
Lasota, J.3
-
9
-
-
0036769966
-
Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review
-
Miettinen M., Majidi M., and Lasota J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur. J. Cancer 38 (2002) 39-51
-
(2002)
Eur. J. Cancer
, vol.38
, pp. 39-51
-
-
Miettinen, M.1
Majidi, M.2
Lasota, J.3
-
11
-
-
16544371910
-
Prevalence of KIT in human tumors
-
Went P.T., Dirnhofer S., Bundi M., Mirlacher M., Schraml P., Mangialaio S., et al. Prevalence of KIT in human tumors. J. Clin. Oncol. 22 (2004) 4514-4522
-
(2004)
J. Clin. Oncol.
, vol.22
, pp. 4514-4522
-
-
Went, P.T.1
Dirnhofer, S.2
Bundi, M.3
Mirlacher, M.4
Schraml, P.5
Mangialaio, S.6
-
12
-
-
0033621733
-
C-kit et tumeurs stromales gastro-intestinales : plus qu'un nouveau marqueur
-
Scoavec J.Y. C-kit et tumeurs stromales gastro-intestinales : plus qu'un nouveau marqueur. Ann. Pathol. 20 (2000) 91-92
-
(2000)
Ann. Pathol.
, vol.20
, pp. 91-92
-
-
Scoavec, J.Y.1
-
13
-
-
0031947592
-
Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
-
Kindblom L.G., Remotti H.E., Aldenborg F., and Meis-Kindblom J.M. Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 152 (1998) 1259-1269
-
(1998)
Am. J. Pathol.
, vol.152
, pp. 1259-1269
-
-
Kindblom, L.G.1
Remotti, H.E.2
Aldenborg, F.3
Meis-Kindblom, J.M.4
-
14
-
-
0032981004
-
Expression of c-Kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumors
-
Seidal T., and Edvardsson H. Expression of c-Kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumors. Histopathology 34 (1999) 416-424
-
(1999)
Histopathology
, vol.34
, pp. 416-424
-
-
Seidal, T.1
Edvardsson, H.2
-
15
-
-
0028908814
-
Gastrointestinal stromal tumors-value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas
-
Miettinen M., Virolainen M., and Sarlomo-Rikala M. Gastrointestinal stromal tumors-value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am. J. Surg. Pathol. 19 (1995) 207-216
-
(1995)
Am. J. Surg. Pathol.
, vol.19
, pp. 207-216
-
-
Miettinen, M.1
Virolainen, M.2
Sarlomo-Rikala, M.3
-
16
-
-
0036301722
-
Longley BJ and al. Diagnosis of GIST: a consensus approach
-
Fletcher C.D.M., Berman J.J., Coless C., Gorstein F., and Lasota J. Longley BJ and al. Diagnosis of GIST: a consensus approach. Hum. Pathol. 33 (2002) 459-465
-
(2002)
Hum. Pathol.
, vol.33
, pp. 459-465
-
-
Fletcher, C.D.M.1
Berman, J.J.2
Coless, C.3
Gorstein, F.4
Lasota, J.5
-
17
-
-
0142121411
-
®) is an active agent for gastrointestinal stromal tumors, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study
-
®) is an active agent for gastrointestinal stromal tumors, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. Eur. J. Cancer 39 (2003) 2006-2011
-
(2003)
Eur. J. Cancer
, vol.39
, pp. 2006-2011
-
-
Verweij, J.1
van Oosterom, A.2
Blay, J.Y.3
Judson, I.4
Rodenhuis, S.5
van der Graaf, W.6
-
18
-
-
0037103424
-
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
-
Demetri G.D., von Mehren M., Blanke C.D., van den Abbeele A.D., Eisenberg B., Roberts P.J., et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347 (2002) 472-480
-
(2002)
N. Engl. J. Med.
, vol.347
, pp. 472-480
-
-
Demetri, G.D.1
von Mehren, M.2
Blanke, C.D.3
van den Abbeele, A.D.4
Eisenberg, B.5
Roberts, P.J.6
|